Waist-to-height Ratio, Lean Mass And Fat Mass I...

Cardiovascular Diseases: Are We Overlooking Som...

Medication Adherence Issues In Patients: Focus ...

Enlisting New Teachers In Clinical Education

Nitric Oxide: A Small Molecule With Diversifyin...

0 votes
Use Of 5 Percent Lidocaine Medicated Plaster To Treat Neuropathic Pain
Author: Correa-illanes G, Roa R, Piñeros Jl, Calderón W
Publisher: Derivative Works
7 pages
One time payment: €0.00
Required subscription: Free
Type of publication: Article
ISBN/ISSN: 1178-7112.
DOI: 10.2147/31868
Follow this publisher

Share this publication:


Objective: The efficacy of 5% lidocaine medicated plaster (LMP) has previously been demonstrated in post-traumatic localized neuropathic pain. This study evaluated the use of LMP in localized neuropathic pain secondary to traumatic peripheral nerve injury.

Patients and methods: This prospective observational study enrolled patients with traumatic injuries to peripheral nerves that were accompanied by localized neuropathic pain of more than 3 months duration. Demographic variables, pain intensity (measured using the numeric rating scale; NRS), answers to the Douleur Neuropathique 4 (DN4) questionnaire, and the size of the painful area were recorded.

Results: Nineteen patients were included, aged (mean ± standard deviation) 41.4 ± 15.7 years. Nerve injuries affected the upper (eight patients) or lower (11 patients) limbs. The mean duration of pain before starting treatment with LMP was 22.6 ± 43.5 months (median 8 months).

Mean baseline values included: NRS 6.7 ± 1.6, painful area 17.8 ± 10.4 cm2  (median 18 cm2), and DN4 score 6.7 ± 1.4. The mean duration of treatment with LMP was 19.5 ± 10.0 weeks (median 17.4 weeks). Mean values after treatment were: NRS 2.8 ± 1.5 ($3 point reduction in 79% of patients, $50% reduction in 57.9% of patients) and painful area 2.1 ± 2.3 cm2  (median 1 cm2 , $50% reduction in 94.7% of patients). Functional improvement after treatment was observed in 14/19 patients (73.7%).


Conclusion: LMP effectively treated traumatic injuries of peripheral nerves which presented with chronic localized neuropathic pain, reducing both pain intensity and the size of the painful area.

About the publisher:

We are a publishing house devoted to reuse CC-BY licensed published materials.


Using CC-BY licenses:


  • Adapt — remix, transform, and build upon the material
  • for any purpose, even commercially.
  • The licensor cannot revoke these freedoms as long as you follow the license terms.


  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others
    from doing anything the license permits.


  • You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
  • No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

Select a payment method